Biotech · Private company
Zhejiang DTRM Biopharma
Track this companyFree. Adds Zhejiang DTRM Biopharma to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- DTRM-555Phase 2 · Relapsed Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- DTRM-505Phase 1 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- DTRM-555Phase 1 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- DTRMWXHS-12Phase 1 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasPHASE2 · TERMINATED · started Apr 24, 2020ClinicalTrials.gov NCT04305444 · fetched Nov 12, 2026
- Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell LymphomasPHASE1 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02900716 · fetched Nov 12, 2026